Control of CCK gene transcription by PACAP in STC-1 cells

Am J Physiol Gastrointest Liver Physiol. 2000 Sep;279(3):G605-12. doi: 10.1152/ajpgi.2000.279.3.G605.

Abstract

The mechanisms by which neuroendocrine stimulants regulate CCK gene transcription are unclear. We examined promoter activation by pituitary adenylate cyclase-activating polypeptide (PACAP), a known CCK secretagogue, in the enteroendocrine cell line STC-1. The promoter region from -70 to -87 bp, relative to the transcriptional start site, contains a composite calcium/cyclic AMP response element (CRE)/activator protein 1 (AP1) site that may bind CRE binding protein (CREB) and AP1. PACAP (with IBMX) stimulated expression of an 87-bp construct 3.35+/-0.36-fold but had no effect on a -70 construct. The effect was blocked by the protein kinase A inhibitor H-89 and by a dominant-negative CREB plasmid. Mutation of the CRE/AP1 site to a canonical CRE site did not affect the response to PACAP, but mutation to a canonical AP1 site prevented it. CREB phosphorylation was increased after PACAP treatment. Electrophoretic mobility shift assay and supershift analysis revealed that CREB and not AP1 bound to the CRE/AP1 site and that PACAP increased the proportion of phosphorylated CREB that was bound. We conclude that PACAP increases CCK gene expression via a cAMP-mediated pathway involving CREB phosphorylation by protein kinase A and activation of a composite CRE/AP1 site.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Cholecystokinin / genetics*
  • Colforsin / pharmacology
  • Cyclic AMP / metabolism
  • Cyclic AMP Response Element-Binding Protein / genetics
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Electrophoresis
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Expression Regulation, Neoplastic / physiology
  • Genes, Reporter
  • Isoquinolines / pharmacology
  • Luciferases / genetics
  • Mice
  • Mutagenesis / physiology
  • Neuroendocrine Tumors
  • Neuropeptides / genetics*
  • Oligonucleotide Probes
  • Phosphorylation
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Promoter Regions, Genetic / physiology
  • Rats
  • Sulfonamides*
  • Transcription Factor AP-1 / genetics
  • Transcription Factor AP-1 / metabolism
  • Transcription, Genetic / physiology*
  • Tumor Cells, Cultured

Substances

  • Adcyap1 protein, mouse
  • Adcyap1 protein, rat
  • Cyclic AMP Response Element-Binding Protein
  • Enzyme Inhibitors
  • Isoquinolines
  • Neuropeptides
  • Oligonucleotide Probes
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Sulfonamides
  • Transcription Factor AP-1
  • Colforsin
  • Cholecystokinin
  • Cyclic AMP
  • Luciferases
  • Cyclic AMP-Dependent Protein Kinases
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
  • Calcium